Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
December 16, 2025
Dr. Jingyi Jessica Li named Donald and Janet K. Guthrie Endowed Chair in Statistics
Funding will help new program head expand applied use of statistics in cancer research
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions
From the Turtle group and collaborators, Clinical Research Division
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
CAR T cells manufacture upgrades
From the Till lab, Clinical Research Division
One family, two sides of cancer
Basic scientist Dr. Wenying Shou’s parents were both treated for — and cured of — their cancers. The similarities end there.
Mustang Bio licenses Fred Hutch CD20 CAR-T immunotherapy for lymphoma trial
New type of immunotherapy for people with B-cell non-Hodgkin lymphoma
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Good News: Dr. Betz Halloran wins award in Rome; Hutch nominated for SLU nonprofit of the year; Obliteride amassed $2.4M in donations
Celebrating faculty and staff achievements
New approach aims to restore immune-powering B cells in cancer patients following successful immunotherapy with CAR T cells
New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy
Patients with advanced lymphoma in remission after T-cell therapy
New study: 7 of 11 trial participants who got two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission
Bike ride to raise cancer funds is personal for 3 'Obliteriders'
For Nancy Evans, Brian Tracy and Dr. Jerry Radich, this weekend’s fundraising bike ride is personal
Can Timothy Ray Brown’s HIV cure be repeated?
'Patient B' joined a Boston research study to find out: Gary Steinkohl’s story — and legacy